On the Confusion of Two Different Diseases Under the Name of Rubella (Rose-Rash).

Dukes, Clement

doi:10.1016/s0140-6736(00)65681-7

Cited by 26 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The term 'fifth disease' was used because parvovirus B19 infection was considered to be the next example of the existing classic four childhood exanthemata: measles, scarlet fever (scarlatina), rubella and 'fourth disease' or Dukes' disease. * 3 In 1975, whilst screening blood donations for hepatitis B, a novel agent was found which could be confused morphologically and serologically with hepatitis B antigen. This was a known property of parvoviruses, but the antigen was novel and was given the name parvovirus B19 because it was found in Panel B, Sample 19 of the laboratory testing kit.…”

Section: History and Nomenclaturementioning

confidence: 99%

Parvovirus B19 infection in human pregnancy

Lamont

Sobel

Vaisbuch

et al. 2010

BJOG

175

139

View full text Add to dashboard Cite

Human parvovirus B19 infection is widespread. Approximately 30-50% of pregnant women are nonimmune, and vertical transmission is common following maternal infection in pregnancy. Fetal infection may be associated with a normal outcome, but fetal death may also occur without ultrasound evidence of infectious sequelae. B19 infection should be considered in any case of nonimmune hydrops. Diagnosis is mainly through serology and polymerase chain reaction.Surveillance requires sequential ultrasound and Doppler screening for signs of fetal anaemia, heart failure and hydrops. Immunoglobulins, antiviral and vaccination are not yet available, but intrauterine transfusion in selected cases can be life saving.

show abstract

Section: History and Nomenclaturementioning

confidence: 99%

Parvovirus B19 infection in human pregnancy

Lamont

Sobel

Vaisbuch

et al. 2010

BJOG

175

139

View full text Add to dashboard Cite

show abstract

“…The clinical course and immune response to parvovirus B19 is biphasic, with a second phase of symptoms presenting with rash, pruritus, or arthralgia approximately 17 to 18 days after vaccination [22,23]. Peripheral polyarthropathy of the hands, wrists, and knees is also characteristic and may be the only manifestation in pregnant women [24].…”

Section: Maternal Infection-clinical Presentationmentioning

confidence: 99%

Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge

Dittmer,

Guimarães,

Peixoto

et al. 2024

JPM

View full text Add to dashboard Cite

Parvovirus B19, a member of the Parvoviridae family, is a human pathogenic virus. It can be transmitted by respiratory secretions, hand-to-mouth contact, blood transfusion, or transplacental transmission. Most patients are asymptomatic or present with mild symptoms such as erythema infectiosum, especially in children. In rare cases, moderate-to-severe symptoms may occur, affecting blood cells and other systems, resulting in anemia, thrombocytopenia, and neutropenia. Non-immune pregnant women are at risk for fetal infection by parvovirus B19, with greater complications if transmission occurs in the first or second trimester. Infected fetuses may not show any abnormalities in most cases, but in more severe cases, there may be severe fetal anemia, hydrops, and even pregnancy loss. Maternal diagnosis of intrauterine parvovirus B19 infection includes IgG and IgM antibody testing. For fetal diagnosis, PCR is performed through amniocentesis. In addition to diagnosing the infection, it is important to monitor the peak of systolic velocity of the middle cerebral artery (PVS-MCA) Doppler to assess the presence of fetal anemia. There is no vaccine for parvovirus B19, and fetal management focuses on detecting moderate/severe anemia by fetal PVS-MCA Doppler, which, if diagnosed, should be treated with intrauterine transfusion by cordocentesis. Prevention focuses on reducing exposure in high-risk populations, particularly pregnant women.

show abstract

“…В 1885 г. Нил Филатов и в 1894 г. Clement Dukes описали данное заболевание как разновидность краснухи. В 1900 г. Clement Dukes идентифицировал дерматит как отдельную нозологическую форму с названиями «болезнь Dukes», «болезнь Филатова» и «четвертая болезнь» [2]. Только в 1979 г. Keith Powell установил стафилококковую этиологию заболевания, и дерматит получил название Staphylococcal scalded skin syndrome [3,4].…”

unclassified